Bayesian Approaches to Clinical Trials and Health-Care Evaluation

Front Cover
John Wiley & Sons, 2004 - Mathematics - 391 pages
0 Reviews
READ ALL ABOUT IT!

David Spiegelhalter has recently joined the ranks of Isaac Newton, Charles Darwin and Stephen Hawking by becoming a fellow of the Royal Society. Originating from the Medical Research Council’s biostatistics unit, David has played a leading role in the Bristol heart surgery and Harold Shipman inquiries.  

Order a copy of this author’s comprehensive text TODAY! 

The Bayesian approach involves synthesising data and judgement in order to reach conclusions about unknown quantities and make predictions. Bayesian methods have become increasingly popular in recent years, notably in medical research, and although there are a number of books on Bayesian analysis, few cover clinical trials and biostatistical applications in any detail. Bayesian Approaches to Clinical Trials and Health-Care Evaluation provides a valuable overview of this rapidly evolving field, including basic Bayesian ideas, prior distributions, clinical trials, observational studies, evidence synthesis and cost-effectiveness analysis.
Covers a broad array of essential topics, building from the basics to more advanced techniques.

  • Illustrated throughout by detailed case studies and worked examples
  • Includes exercises in all chapters
  • Accessible to anyone with a basic knowledge of statistics
  • Authors are at the forefront of research into Bayesian methods in medical research
  • Accompanied by a Web site featuring data sets and worked examples using Excel and WinBUGS - the most widely used Bayesian modelling package


Bayesian Approaches to Clinical Trials and Health-Care Evaluation is suitable for students and researchers in medical statistics, statisticians in the pharmaceutical industry, and anyone involved in conducting clinical trials and assessment of health-care technology.

 

What people are saying - Write a review

We haven't found any reviews in the usual places.

Contents

III
1
IV
2
V
3
VII
4
VIII
9
X
10
XI
14
XII
20
LIX
181
LXII
182
LXIII
184
LXIV
187
LXV
189
LXVI
202
LXVII
224
LXVIII
227

XIII
22
XIV
31
XV
34
XVI
46
XVIII
49
XX
51
XXI
54
XXII
56
XXIII
57
XXV
62
XXVI
64
XXVII
73
XXVIII
74
XXIX
75
XXX
79
XXXI
80
XXXII
85
XXXIII
90
XXXV
91
XXXVI
100
XXXVII
102
XXXVIII
112
XXXIX
113
XL
115
XLI
116
XLII
117
XLIII
121
XLIV
122
XLV
124
XLVI
127
XLVII
136
XLIX
139
L
140
LI
147
LII
148
LIII
157
LIV
165
LV
167
LVI
174
LVII
176
LVIII
177
LXIX
228
LXX
235
LXXI
237
LXXII
242
LXXIII
244
LXXIV
245
LXXV
247
LXXVI
251
LXXVII
252
LXXVIII
253
LXXIX
258
LXXX
262
LXXXI
263
LXXXII
267
LXXXIII
268
LXXXIV
282
LXXXV
285
LXXXVI
298
LXXXVII
299
LXXXIX
305
XCII
306
XCIII
308
XCIV
310
XCV
312
XCVI
315
XCVII
320
XCVIII
322
XCIX
329
C
335
CI
341
CII
343
CIII
344
CIV
345
CVI
349
CVII
350
CVIII
353
CXI
354
CXII
355
CXIII
357
CXIV
381
Copyright

Other editions - View all

Common terms and phrases

Popular passages

Page 380 - Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2).
Page 376 - Shepherd J, Blauw GJ, Murphy MB, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial.
Page 378 - The asymptotic joint distribution of the efficient scores test for the proportional hazards model calculated over time.
Page 380 - Combining single patient (N-of-1) trials to estimate population treatment effects and to evaluate individual patient responses to treatment.
Page 380 - T. and Woods, K. (1993) Intravenous magnesium in acute myocardial infarction: an effective, safe, simple and inexpensive intervention. Circulation, 87, 2043-2046.

References to this book

All Book Search results »